Eiger nabs the first FDA approval for Progeria, an ultra-rare premature aging disease, with an old Merck drug
Eiger BioPharmaceuticals $EIGR has received an FDA OK for a drug Merck licensed to them at no cost — and now reportedly plans to charge a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
